Method for identification, isolation and production of antigens to a specific pathogen
Described is a method for identification, isolation and production of hyperimmune serum-reactive antigens from a specific pathogen, a tumor, an allergen or a tissue or host prone to auto-immunity, said antigens being suited for use in a vaccine for a given type of animal or for humans, which is characterized by the following steps: providing an antibody preparation, providing at least one expression library, identifying antigens which bind, screening the identified antigens, identifying the hyperimmune serum-reactive antigen portion of said identified antigens and which hyperimmune serum-reactive antigens bind to a relevant portion of said individual antibody optionally isolating said hyperimmune serum-reactive antigens and producing said hyperimmune serum-reactive antigens by chemical or recombinant methods.
1. An isolated antigen consisting of the sequence of SEQ ID NO: 277 or an antigenic fragment of SEQ ID NO: 277, wherein the antigenic fragment of SEQ ID NO: 277 comprises the sequence of one or more of amino acids 9-31, 36-45, 59-67, 71-81, 86-94, 96-107, 111-122, 127-140, 153-168, 180-211, 218-224, 226-251, 256-270, 272-289, 299-305, 310-323, 334-341, 345-353, 358-364, 369-379, 384-390, 396-410, 400-413, 404-413, 417-423, 429-442, 454-464, 470-477, 497-505 and 540-554 of SEQ ID NO: 277.
2. The isolated antigen of claim 1 , wherein the antigenic fragment of SEQ ID NO: 277 comprises at least 8 amino acids.
3. A preparation comprising at least one antigen of claim 1 .
4. The preparation of claim 3 , further comprising a pharmaceutically acceptable carrier and/or excipient.
5. The preparation of claim 4 , further comprising an immunostimulatory substance selected from the group of polycationic substances, polycationic peptides, immunostimulatory deoxynucleotides, alum, Freund's complete adjuvants, Freund's incomplete adjuvants, neuroactive compounds, human growth hormone, or combinations thereof.
6. The isolated antigen of claim 1 , further comprising an extra amino acid sequence at the C-terminus.
7. The isolated antigen of claim 6 , wherein the extra amino acid sequence is a HIS-tag or a Strep-tag.
8. An isolated antigenic fragment, wherein the isolated antigenic fragment is selected from the group consisting of amino acids 9-31, 36-45, 59-67, 71-81, 86-94, 96-107, 111-122, 127-140, 153-168, 180-211, 218-224, 226-251, 256-270, 272-289, 299-305, 310-323, 334-341, 345-353, 358-364, 369-379, 384-390, 396-410, 400-413, 404-413, 429-442, 454-464, 470-477, 497-505 and 540-554 of SEQ ID NO: 277.
9. A method of eliciting an immune response against Staphylococcus epidermidis comprising administering to a subject an effective amount of an isolated antigen consisting of the sequence of SEQ ID NO: 277 or an antigenic fragment of SEQ ID NO: 277, wherein the antigenic fragment of SEQ ID NO: 277 comprises the sequence of one or more of amino acids 9-31, 36-45, 59-67, 71-81, 86-94, 96-107, 111-122, 127-140, 153-168, 180-211, 218-224, 226-251, 256-270, 272-289, 299-305, 310-323, 334-341, 345-353, 358-364, 369-379, 384-390, 396-410, 400-413, 404-413, 417-423, 429-442, 454-464, 470-477, 497-505 and 540-554 of SEQ ID NO: 277.
10. The method of claim 9 , wherein the antigenic fragment of SEQ ID NO: 277 comprises at least 8 amino acids.
11. The method of claim 9 , wherein the antigenic fragment comprises at least 7 amino acids.
12. The method of claim 9 , wherein the antigenic fragment comprises at least 9 amino acids.
13. The method of claim 9 , further comprising administering an adjuvant to the subject.
14. The method of claim 13 , wherein the adjuvant is selected from the group consisting of polycationic peptides, immunostimulatory deoxynucleotides, alum, Freund's incomplete adjuvant, and human growth hormone.
15. The method of claim 9 , wherein the subject is human.
16. A method of making a preparation comprising obtaining the antigen of claim 1 , and admixing said antigen with a pharmaceutically acceptable carrier and/or excipient.